SweetValueLab
Write for us

Corteva, Inc. — Wall Street Analyst Estimates & Price Targets

CTVA
NYSEBasic MaterialsAgricultural InputsCIK 0001755672corteva.comAbout CTVA
Last close · Oct 16, 202612.88+0.00 (+0.00%)
Market cap$8.6B

9 firms' latest targets, last 90 days: median $17.00 ($15.00–$101.00), 32% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$20.0$40.0$60.0$80.0$100NovJan 2026MarMayJulSep2025-10-22 · Oppenheimer: $75.02025-10-30 · UBS: $81.02025-11-07 · Oppenheimer: $76.02026-01-16 · Mizuho Securities: $80.02026-01-27 · Oppenheimer: $78.02026-02-05 · RBC Capital: $89.02026-02-05 · Oppenheimer: $86.02026-02-05 · Goldman Sachs: $88.02026-02-05 · Wells Fargo: $85.02026-02-09 · UBS: $80.02026-02-17 · Mizuho Securities: $82.02026-04-09 · UBS: $88.02026-04-21 · Wells Fargo: $90.02026-04-24 · RBC Capital: $95.02026-05-28 · Morgan Stanley: $95.02026-06-09 · UBS: $86.02026-06-11 · Barclays: $91.02026-07-02 · Mizuho Securities: $96.02026-07-14 · Mizuho Securities: $97.02026-07-21 · RBC Capital: $1032026-08-03 · Deutsche Bank: $1012026-08-03 · BMO Capital: $1002026-09-16 · BMO Capital: $95.02026-09-16 · New Street: $95.02026-09-16 · UBS: $90.02026-09-24 · Oppenheimer: $95.02026-10-02 · BMO Capital: $15.02026-10-02 · Morgan Stanley: $18.02026-10-05 · New Street: $17.02026-10-05 · Oppenheimer: $17.02026-10-07 · RBC Capital: $17.02026-10-07 · KeyBanc: $17.02026-10-08 · Goldman Sachs: $20.02026-10-12 · UBS: $15.0
$20.0$40.0$60.0$80.0$100NovFebMayAug

Each firm's latest target

last 90 days · 9 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-12UBS$15.00$90.00▼ 83%+16%+16%
2026-10-08Goldman Sachs$20.00$88.00▼ 77%+38%+55%
2026-10-07RBC Capital$17.00$103.00▼ 83%+22%+32%
2026-10-07KeyBanc$17.00——+22%+32%
2026-10-05New Street$17.00$95.00▼ 82%+43%+32%
2026-10-05Oppenheimer$17.00$95.00▼ 82%+43%+32%
2026-10-02BMO Capital$15.00$95.00▼ 84%+19%+16%
2026-10-02Morgan Stanley$18.00$95.00▼ 81%+43%+40%
2026-08-03Deutsche Bank$101.00——+30%+684%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2022reported$17.5B+11%$1.58-33%est. $17.4B+0%est. $2.576
2023reported$17.2B-1%$1.03-35%est. $17.1B+1%est. $2.6015
2024reported$16.9B-2%$1.30+26%est. $16.9B+0%est. $0.3811
2025reported$17.4B+3%$1.60+23%est. $17.7B-2%est. $0.5013
2026$17.5B+1%$0.57+14%$17.4B–$17.6B$0.36–$1.087
2027$8.1B-54%$0.73+27%$8.0B–$8.1B$0.56–$0.948
2028$8.3B+3%$0.84+16%$7.8B–$11.0B$0.68–$0.969
2029$8.6B+3%$0.77-8%$8.2B–$10.4B$0.74–$0.994
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.